GLI1 and cancer: Inhibition of Gli may be more effective than inhibition of Smo in preventing downstream SHh gene activation given evidence for non-canonical Gli activation independent of SHh in cancer cells and evidence that Gli is a target of other oncogenic signaling pathways [17–22].